Park Ha Biological Technology Co., Ltd. Ordinary Shares
BYAH · NASDAQ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 1.92M | 1.41M | 197.02K | 191.30K | 0.37 |
| 2023 FY | 2.46M | 2.15M | 1.18M | 852.04K | 1.63 |
| 2024 FY | 2.38M | 2.19M | 793.71K | 478.56K | 0.92 |
| 2025 FY | 2.52M | 2.38M | -24.15M | -24.36M | -41.38 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 2.52M | 2.37M | 574.71K | 26.19K | 150.28K |
| 2023 FY | 2.26M | 1.25M | 1.03M | 31.46K | 1.01M |
| 2024 FY | 3.08M | 1.58M | 547.50K | 70.32K | 1.51M |
| 2025 FY | 5.95M | 1.96M | 3.79M | 180.17K | 3.99M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 1.44M | -11.89K | 1.43M | — | 502.03K |
| 2023 FY | 126.54K | -22.68K | 103.86K | — | 458.92K |
| 2024 FY | 960.47K | -85.57K | 874.90K | — | -486.14K |
| 2025 FY | 85.85K | -88.82K | -2.97K | — | 3.24M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 12.55M | 12.00M | — | — | — |
| 2023 FY | 12.55M | 11.55M | — | — | — |
| 2024 FY | 12.55M | 12.07M | — | — | — |
| 2025 FY | 11.03M | 7.42M | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 1.24M | 1.18M | -19.72M | -19.84M | -33.76 |
| 2025 Q3 | 642.82K | 600.81K | -2.22M | -2.26M | -3.54 |
| 2025 Q4 | 1.29M | 1.11M | -4.43M | -4.53M | -7.61 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2024 Q4 | 3.08M | 1.58M | 547.50K | 70.32K | 1.51M |
| 2025 Q2 | 5.83M | 1.58M | 1.35M | 91.46K | 4.25M |
| 2025 Q3 | 5.95M | 1.96M | 3.79M | 180.17K | 3.99M |
| 2025 Q4 | 5.95M | 1.96M | 3.79M | 180.17K | 3.99M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 245.43K | -2.21K | 243.22K | — | 803.79K |
| 2025 Q3 | -79.79K | -43.31K | -123.10K | — | — |
| 2025 Q4 | -159.58K | -86.61K | -246.19K | — | 2.44M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 14.07M | 12.81M | — | — | — |
| 2025 Q3 | 15.33M | 11.72M | — | — | — |
| 2025 Q4 | 11.14M | 7.54M | — | — | — |